Porkert, Stefanie, et al. “Long-Term Therapeutic Success of Intravenous Rituximab in 26 Patients With Indolent Primary Cutaneous B-Cell Lymphoma”. Acta Dermato-Venereologica, vol. 101, no. 2, Feb. 2021, p. adv00383, doi:10.2340/00015555-3746.